A prospective, longitudinal, non-comparator, non-randomized observational cohort study to assess the quality of life in adult patients affected by hypertrophic cardiomyopathy and thoracic aortic dilatations who are not amenable to surgery, as well as those affected radiation-induced cardiac disease caused by radiation therapy.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Global domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline.
Timeframe: 9 months after baseline visit
Physical domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline
Timeframe: 9 months after baseline visit
Emotional domain of Cardiac Quality of Life Survey assessed 3 months after baseline as compared to baseline.
Timeframe: 9 months after baseline visit
Social domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline.
Timeframe: 9 months after baseline visit
Spiritual domain of quality of life assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Timeframe: 9 months after baseline visit
Self-efficacy assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Timeframe: 9 months after baseline visit
Resilience assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Timeframe: 9 months after baseline visit
Impact of heritability of cardiac disease assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Timeframe: 9 months after baseline visit
Impact of radiation-induced heart disease (RIHD) assessed at baseline visit in the outpatient clinic.
Timeframe: Baseline visit